文献速递造血干细胞移植与细胞治疗淋巴瘤

缺乏HDAC11的T细胞效应功能增强并在小鼠模型中介导增强的同种反应性

T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model.
PubMed 文献 · Blood · 2017-05-26

本研究利用EGFP-HDAC11转基因报告小鼠和HDAC11敲除小鼠,发现HDAC11在效应T细胞中表达低于初始和中央记忆T细胞,且T细胞活化后其表达下降。HDAC11缺失的T细胞增殖、促炎细胞因子产生和效应分子表达增强,并上调Eomes和Tbet;过表达HDAC11则降低这些基因表达。在体内,HDAC11敲除T细胞抵抗免疫耐受诱导,加速急性移植物抗宿主病(GVHD)发生,并在小鼠B细胞淋巴瘤模型中显著减轻肿瘤负荷。

要点

  • HDAC11在效应T细胞中表达低于初始和中央记忆T细胞,活化后表达下降。
  • HDAC11敲除T细胞增殖、促炎细胞因子和效应分子表达增强,Eomes和Tbet上调。
  • HDAC11敲除T细胞抵抗耐受诱导,加速GVHD,并减轻小鼠B细胞淋巴瘤肿瘤负荷。

核心结论

  • HDAC11是T细胞效应表型和功能的负向表观遗传调控因子。

研究设计与样本

  • 研究使用EGFP-HDAC11转基因报告小鼠和HDAC11敲除小鼠,在小鼠模型中开展体外和体内实验。

主要发现

  • HDAC11在效应T细胞中表达低于初始和中央记忆T细胞,静息T细胞活化后HDAC11表达下降。
  • HDAC11敲除T细胞增殖、促炎细胞因子产生和效应分子表达增强,Eomes和Tbet表达增加;过表达HDAC11则降低这些基因表达。
  • 染色质免疫沉淀显示静息T细胞中HDAC11存在于Eomes和Tbet基因启动子,T细胞活化后迅速解离。
  • 体内HDAC11敲除T细胞抵抗耐受诱导,并加速急性GVHD发生,伴T细胞增殖增加及干扰素-γ、肿瘤坏死因子和EOMES表达增加。
  • 过继转移HDAC11敲除T细胞在小鼠B细胞淋巴瘤模型中显著减轻肿瘤负荷。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Histone acetylation and the families of enzymes responsible for controlling these epigenetic marks have been implicated in regulating T-cell maturation and phenotype. Here, we demonstrate a previously undefined role of histone deacetylase 11 (HDAC11) in regulating T-cell effector functions. Using EGFP-HDAC11 transgenic reporter mice, we found that HDAC11 expression was lower in effector relative to naive and central memory T-cell populations, and activation of resting T cells resulted in its decreased expression. Experiments using HDAC11 knockout (KO) mice revealed that T cells from these mice displayed enhanced proliferation, proinflammatory cytokine production, and effector molecule expression. In addition, HDAC11KO T cells had increased expression of Eomesodermin (Eomes) and TBX21 (Tbet), transcription factors previously shown to regulate inflammatory cytokine and effector molecule production. Conversely, overexpression of HDAC11 resulted in decreased expression of these genes. Chromatin immunoprecipitation showed the presence of HDAC11 at the Eomes and Tbet gene promoters in resting T cells, where it rapidly disassociated following T-cell activation. In vivo, HDAC11KO T cells were refractory to tolerance induction. HDAC11KO T cells also mediated accelerated onset of acute graft-versus-host disease (GVHD) in a murine model, characterized by increased proliferation of T cells and expression of interferon-γ, tumor necrosis factor, and EOMES. In addition, adoptive transfer of HDAC11KO T cells resulted in significantly reduced tumor burden in a murine B-cell lymphoma model. Taken together, these data demonstrate a previously unknown role of HDAC11 as a negative epigenetic regulator of T-cell effector phenotype and function.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Woods DM, Woan KV, Cheng F, et al. T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model. Blood. 2017. PMID: 28550044. doi:10.1182/blood-2016-08-731505

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。